Amgen is a biopharmaceutical company based in Thousand Oaks, California, that develops and sells biological medicines. It last closed at $457.93 on Nov 17, down 0.95% on the day. AMGN reports earnings on Tue, Feb 2, 2027. The average 12-month price target from 22 analysts is $461.41 (+0.8% from the last close), with a high of $536.00 and a low of $398.00. Analyst consensus is Hold, based on the latest ratings from 22 firms (8 buy, 14 hold, 0 sell). Over the past 90 days StreetAlpha recorded 17 whale options trades in AMGN, 53% of them bullish and 47% bearish. In the past 30 days there were 25 dark pool prints totaling $29.1M, the largest $6.3M.
Each firm's latest rating on AMGN in the past 90 days
Average 12-month target
$461.41
▲ 0.8% upside
Based on 22 analysts who set a price target on AMGN in the past 90 days. The average target is $461.41, with a high of $536.00 and a low of $398.00, compared with the last close of $457.93.
Highest target$536.00
Average target$461.41
Lowest target$398.00
Latest rating changes
BarclaysTarget raised
Nov 16Hold$400 → $430
Argus ResearchTarget raised
Nov 12Buy$460 → $515
Freedom BrokerDowngrade
Nov 6Hold$470
Leerink PartnersMaintained
Nov 5Hold$464
GuggenheimTarget raised
Nov 5Hold$378 → $435
Date
Firm
Action
Rating
Price target
Nov 16
Barclays
Target raised
Hold
$400 → $430
Nov 12
Argus Research
Target raised
Buy
$460 → $515
Nov 6
Freedom Broker
Downgrade
Hold
$470
Nov 5
Leerink Partners
Maintained
Hold
$464
Nov 5
Guggenheim
Target raised
Hold
$378 → $435
Loading…
Technical Analysis
AMGN · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is 17% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 55). The nearest support is the Pivot S1 at $452.81, and the nearest resistance the Pivot at $458.15.
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 2.5%/day
Key levels
$483.9952 week high+5.7%
$483.99Swing high (Nov 5)+5.7%
$463.27Pivot R1+1.2%
$458.6720 day average+0.2%
$458.15Pivot+0.0%
$457.93Last close
$452.81Pivot S1−1.1%
$447.04Swing low (Nov 6)−2.4%
$427.1050 day average−6.7%
$412.43100 day average−9.9%
$382.18200 day average−16.5%
$312.3952 week low−31.8%
Indicators
RSI (14)
55.31
Middle of its range
Neutral
MACD
9.78
Below its signal line
Bearish
Stochastic
46.6
Middle of its range
Neutral
ADX (14)
36.0
Trending up
Williams %R
-70.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-3.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.7%
Change over 10 sessions
Bearish
ATR (14)
$11.48
Typical daily range, 2.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 5.6%/day
Key levels
$483.9952 week high+5.7%
$483.99Swing high (Nov 5)+5.7%
$463.27Pivot R1+1.2%
$458.6720 day average+0.2%
$458.15Pivot+0.0%
$457.93Last close
$452.81Pivot S1−1.1%
$447.04Swing low (Nov 6)−2.4%
$427.1050 day average−6.7%
$412.43100 day average−9.9%
$382.18200 day average−16.5%
$312.3952 week low−31.8%
Indicators
RSI (14)
64.19
Strong, overbought above 70
Neutral
MACD
25.66
Above its signal line
Bullish
Stochastic
79.3
Middle of its range
Neutral
ADX (14)
30.6
Trending up
Williams %R
-23.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
110.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+21.4%
Change over 10 sessions
Bullish
ATR (14)
$25.44
Typical daily range, 5.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for AMGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AMGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed9 bullish and 8 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow AMGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AMGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AMGN is in one of them and how their past AMGN trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Amgen
Amgen is a biopharmaceutical company based in Thousand Oaks, California. It develops and sells biological products, which are medicines made from biological sources rather than diagnostic substances. Its medicines are used by patients and the healthcare providers who treat them. The company is a multinational business with operations in several countries.